Jump to main content
Jump to site search

Issue 12, 2009
Previous Article Next Article

Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis

Author affiliations

Abstract

Many eukaryotic and prokaryotic proteins remain disordered under physiological conditions and often acquire a stable secondary structure on binding to their cellular targets. Though the process of binding is still under analysis, it has been found that the flexibility of proteins can add to their functionality. This motivated us to explore intrinsically disordered proteins (IDPs) as drug targets. In silico studies have been carried out on Mycobacterium tuberculosis, which, with emergence of hyper-virulent and drug resistant strains, XDRs and MDRs, is one of the most dreaded pathogens in the modern world. Our study reports 13 IDPs as potential drug targets, and three of them—FtsW (Rv2154c), GlmU (Rv1018c) and Obg (Rv2440c)—are chosen as key proteins and are described in detail. Future applications of this method can provide new insight into understanding the molecular mechanism of IDPs and their potential role as drug targets.

Graphical abstract: Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 18 Mar 2009, accepted on 18 May 2009, published on 15 Jul 2009 and first published online on 15 Jul 2009


Article type: Paper
DOI: 10.1039/B905518P
Citation: Mol. BioSyst., 2009,5, 1752-1757
  •   Request permissions

    Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis

    M. Anurag and D. Dash, Mol. BioSyst., 2009, 5, 1752
    DOI: 10.1039/B905518P

Search articles by author